Onward Therapeutics Announces IMPD Approval for Its Subsidiary Emercell to Start Clinical Investigation of Allogeneic NK Cell Therapy OT-C001 in Combination with Rituximab

EPALINGES, Switzerland and PARIS, April 22, 2025 /PRNewswire/ — Onward Therapeutics SA,…

MIMARU Unveils Japan's First Free Trilingual Accessible Travel Guide — Milestone toward Truly Inclusive Tourism

TOKYO, April 22, 2025 /PRNewswire/ — Cosmos Hotel Management Co., Ltd., the…

Inner Mongolia acts as green power bank

BEIJING, April 21, 2025 /PRNewswire/ — A news report from chinadaily.com.cn: The Inner…

Teads and Mercedes-Benz Drive Brand Lift with Thailand's First Connected TV Campaign

SINGAPORE, April 22, 2025 /PRNewswire/ — Teads, the global media platform, has…

See You in Quzhou: China-US People-to-People Exchange Activities Launched

QUZHOU, China, April 22, 2025 /PRNewswire/ — Against the backdrop of the…

Shahzaib Shah: The Pakistani Ethical Hacker Catching Global Vulnerabilities

Empowering a new generation, Shahzaib Shah of SSSn is not only securing…

NEC Indonesia Achieves ISO/IEC 27001:2022 Certification, Demonstrating Commitment to Information Technology Security

JAKARTA, Indonesia, April 22, 2025 /PRNewswire/ — NEC Indonesia has successfully obtained…

NopalCyber Hires New Head of Sales to Scale Impressive Growth in India

Industry veteran Manish Kalra will help drive growing demand in the region for…